Completed
Evaluation of Virologic, Immunologic, and Clinical Parameters of Participants in HIVNET 014 Who Become Infected With HIV-1
Led by National Institute of Allergy and Infectious Diseases (NIAID) · Updated on 2008-09-12
N/A
Participants Needed
11
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate the long-term consequences of HIV-1 infections that occurred in association with known, but discouraged, high-risk behaviors in persons who have received HIV candidate vaccines or placebo in HIVNET 014. Doctors need to look at how these patients respond to HIV infection in order to develop new HIV vaccines and other treatments for HIV and AIDS. Patients who receive HIV vaccines are sometimes protected from HIV infection. More often, these patients become HIV-positive but experience a boost in their immune system that helps their bodies fight HIV. Doctors need to look at how these patients respond to HIV infection in order to develop new HIV vaccines and other treatments for HIV and AIDS.
CONDITIONS
Official Title
A Study to Monitor the Health of Participants in HIVNET 014 Who Become Infected With HIV-1
Who Can Participate
Eligibility Criteria
You may qualify if you...
Inclusion Criteria
Patients may be eligible for this study if they:
- Become infected with HIV while participating in HIVNET 014, or if they are an HIV-positive partner (sexual or needle-sharing) of a HIVNET 014A participant.
- Are able and willing to provide written informed consent.
Exclusion Criteria
Patients will not be eligible for this study if they:
- Have a serious psychiatric or psychological disorder that would prevent them from completing the study.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
Trial Site Locations
Total: 11 locations
1
San Francisco Dept of Hlth / AIDS Office
San Francisco, California, United States, 94102
Status Unknown
2
Denver Dept of Public Health / HIVNET
Denver, Colorado, United States, 80204
Status Unknown
3
Univ of Illinois Chicago / Howard Brown Hlth Ctr
Chicago, Illinois, United States, 60612
Status Unknown
4
Howard Brown Health Ctr / HIVNET
Chicago, Illinois, United States, 60657
Status Unknown
5
Fenway Community Health Ctr / HIVNET
Boston, Massachusetts, United States, 02115
Status Unknown
6
New York Univ Med Ctr
New York, New York, United States, 10016
Status Unknown
7
New York Blood Ctr
The Bronx, New York, United States, 10456
Status Unknown
8
Univ of Pennsylvania / HIVNET
Philadelphia, Pennsylvania, United States, 19104
Status Unknown
9
Mem Hosp of Rhode Island
Pawtucket, Rhode Island, United States, 02860
Status Unknown
10
Miriam Hosp
Providence, Rhode Island, United States, 02906
Status Unknown
11
Univ of Washington
Seattle, Washington, United States, 98104
Status Unknown
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here